BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 12975244)

  • 1. Ventricular remodeling after infarction and the extracellular collagen matrix: when is enough enough?
    Jugdutt BI
    Circulation; 2003 Sep; 108(11):1395-403. PubMed ID: 12975244
    [No Abstract]   [Full Text] [Related]  

  • 2. Integration of concepts: cardiac extracellular matrix remodeling after myocardial infarction.
    Cleutjens JP; Creemers EE
    J Card Fail; 2002 Dec; 8(6 Suppl):S344-8. PubMed ID: 12555143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory cytokines and postmyocardial infarction remodeling.
    Nian M; Lee P; Khaper N; Liu P
    Circ Res; 2004 Jun; 94(12):1543-53. PubMed ID: 15217919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular matrix remodeling attenuated after experimental postinfarct left ventricular aneurysm repair.
    Hsu CP; Huang CY; Wang JS; Sun PC; Shih CC
    Ann Thorac Surg; 2008 Oct; 86(4):1243-9. PubMed ID: 18805169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intramyocardial injection of tannic acid attenuates postinfarction remodeling: a novel approach to stabilize the breaking extracellular matrix.
    Zhang H; Zhu SJ; Wang D; Wei YJ; Hu SS
    J Thorac Cardiovasc Surg; 2009 Jan; 137(1):216-22, 222e1-2. PubMed ID: 19154928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial proteases and matrix remodeling in inflammatory heart disease.
    Rutschow S; Li J; Schultheiss HP; Pauschinger M
    Cardiovasc Res; 2006 Feb; 69(3):646-56. PubMed ID: 16417902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective targeting and timing of matrix metalloproteinase inhibition in post-myocardial infarction remodeling.
    Yarbrough WM; Mukherjee R; Escobar GP; Mingoia JT; Sample JA; Hendrick JW; Dowdy KB; McLean JE; Lowry AS; O'Neill TP; Spinale FG
    Circulation; 2003 Oct; 108(14):1753-9. PubMed ID: 12975256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relevance of matrix metalloproteinases and their inhibitors after myocardial infarction: a temporal and spatial window.
    Vanhoutte D; Schellings M; Pinto Y; Heymans S
    Cardiovasc Res; 2006 Feb; 69(3):604-13. PubMed ID: 16360129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function.
    Spinale FG
    Physiol Rev; 2007 Oct; 87(4):1285-342. PubMed ID: 17928585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective targeting of matrix metalloproteinase inhibition in post-infarction myocardial remodeling.
    Apple KA; Yarbrough WM; Mukherjee R; Deschamps AM; Escobar PG; Mingoia JT; Sample JA; Hendrick JW; Dowdy KB; McLean JE; Stroud RE; O'Neill TP; Spinale FG
    J Cardiovasc Pharmacol; 2006 Feb; 47(2):228-35. PubMed ID: 16495760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High dose aspirin and left ventricular remodeling after myocardial infarction: aspirin and myocardial infarction.
    Adamek A; Hu K; Bayer B; Wagner H; Ertl G; Bauersachs J; Frantz S
    Basic Res Cardiol; 2007 Jul; 102(4):334-40. PubMed ID: 17340057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implications of myocardial matrix remodeling by adipokines in obesity-related heart failure.
    Schram K; Sweeney G
    Trends Cardiovasc Med; 2008 Aug; 18(6):199-205. PubMed ID: 19185809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenytoin can accelerate the healing process after experimental myocardial infarction?
    Zhou X; Li YM; Ji WJ; Jiang TM; Sun XN; Zhu Y; Shi R
    Int J Cardiol; 2006 Feb; 107(1):21-9. PubMed ID: 15996772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preservation of cardiac extracellular matrix by passive myocardial restraint: an emerging new therapeutic paradigm in the prevention of adverse remodeling and progressive heart failure.
    Shah PK
    Circulation; 2005 Aug; 112(9):1245-7. PubMed ID: 16129809
    [No Abstract]   [Full Text] [Related]  

  • 15. Extracellular matrix remodeling in canine and mouse myocardial infarcts.
    Dobaczewski M; Bujak M; Zymek P; Ren G; Entman ML; Frangogiannis NG
    Cell Tissue Res; 2006 Jun; 324(3):475-88. PubMed ID: 16496177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted deletion of nuclear factor kappaB p50 enhances cardiac remodeling and dysfunction following myocardial infarction.
    Timmers L; van Keulen JK; Hoefer IE; Meijs MF; van Middelaar B; den Ouden K; van Echteld CJ; Pasterkamp G; de Kleijn DP
    Circ Res; 2009 Mar; 104(5):699-706. PubMed ID: 19168865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biglycan is required for adaptive remodeling after myocardial infarction.
    Westermann D; Mersmann J; Melchior A; Freudenberger T; Petrik C; Schaefer L; Lüllmann-Rauch R; Lettau O; Jacoby C; Schrader J; Brand-Herrmann SM; Young MF; Schultheiss HP; Levkau B; Baba HA; Unger T; Zacharowski K; Tschöpe C; Fischer JW
    Circulation; 2008 Mar; 117(10):1269-76. PubMed ID: 18299507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Healing after myocardial infarction.
    Ertl G; Frantz S
    Cardiovasc Res; 2005 Apr; 66(1):22-32. PubMed ID: 15769445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative stress and left ventricular remodelling after myocardial infarction.
    Hori M; Nishida K
    Cardiovasc Res; 2009 Feb; 81(3):457-64. PubMed ID: 19047340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac mast cell regulation of matrix metalloproteinase-related ventricular remodeling in chronic pressure or volume overload.
    Janicki JS; Brower GL; Gardner JD; Forman MF; Stewart JA; Murray DB; Chancey AL
    Cardiovasc Res; 2006 Feb; 69(3):657-65. PubMed ID: 16376324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.